CHIRHOSTIM Drug Patent Profile
✉ Email this page to a colleague
When do Chirhostim patents expire, and what generic alternatives are available?
Chirhostim is a drug marketed by Chirhoclin and is included in one NDA.
The generic ingredient in CHIRHOSTIM is secretin synthetic human. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the secretin synthetic human profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHIRHOSTIM?
- What are the global sales for CHIRHOSTIM?
- What is Average Wholesale Price for CHIRHOSTIM?
Summary for CHIRHOSTIM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 6 |
What excipients (inactive ingredients) are in CHIRHOSTIM? | CHIRHOSTIM excipients list |
DailyMed Link: | CHIRHOSTIM at DailyMed |
Recent Clinical Trials for CHIRHOSTIM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Orlando Health, Inc. | Phase 3 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 1/Phase 2 |
ChiRhoClin, Inc. | N/A |
US Patents and Regulatory Information for CHIRHOSTIM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chirhoclin | CHIRHOSTIM | secretin synthetic human | FOR SOLUTION;INTRAVENOUS | 021256-001 | Apr 9, 2004 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chirhoclin | CHIRHOSTIM | secretin synthetic human | FOR SOLUTION;INTRAVENOUS | 021256-002 | Jun 21, 2007 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |